As men grow older, hormone fluctuations could cause fatigue, lower libido, depression and other symptoms. Despite documented health risks, aggressive marketing campaigns have encouraged the notion that testosterone replacement therapy (TRT) is a “cure-all” for the effects of normal aging.
Recently, the Food and Drug Administration (FDA) launched an investigation into testosterone therapy after receiving reports of heart attack, stroke and premature death in older men.
In November 2013, a study conducted by the Journal of the American Medical Association showed that men who received TRT had a 30 percent increased risk of heart attack, stroke or death. The average participant in the study was about 60 years old, and a large percentage had underlying heart conditions.
In 2010, the New England Journal of Medicine had to stop a similar study before it was completed, because subjects showed an increased rate of heart attacks and other cardiovascular issues.
Testosterone levels can be raised naturally through changes in diet, increased exercise and vitamin supplements, but drug companies continue to market TRT to people who are most vulnerable to the drug’s harmful side effects. Business is booming, and consumer health is secondary to their bottom line.
Proffitt & Cox – South Carolina injury lawyers